Available from: arXiv GLP-1 receptor agonists effect on cognitive function in diabetes: a systematic review / meta-analysis. (Monney et al., 2023) repeated to emphasize the evidence in people with T2DM
The oldest citation is from 2007, and 93% of the references were published in the last 6 years (2018 to 2024)
Zhang, S., Shen, J., Li, D
If you take insulin or sulfonylureas alongside your GLP-1 medication, discuss any timing changes with your provider
How to Tell the Difference
Pharmaceutical companies have also invested heavily in direct-to-patient marketing, with television commercials and online ads promoting the benefits of their brand names for weight loss and diabetes